Dana Farber Institute — Boston, Massachusetts

Dana Farber Institute is a clinical research site located in Boston, Massachusetts, United States 02215.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Dana Farber Institute has participated in 2 clinical trials.

Therapeutic areas: Acute Lymphoblastic Leukemia, Sarcoma.

Sponsors: Amgen Research (Munich) GmbH, European Organisation for Research and Treatment of Cancer - EORTC.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Dana Farber Institute?

Dana Farber Institute has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Dana Farber Institute conducted?

Dana Farber Institute has 2 clinical trials on record. Their work covers Acute Lymphoblastic Leukemia, Sarcoma.

Is Dana Farber Institute accredited by Crixeo Health?

Dana Farber Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Dana Farber Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.